DEFA14A: Nevro Corp. Sets Date for 2024 Annual Stockholder Meeting

Sentiment:

Proxy Statement


Nevro Corp. will hold its annual stockholder meeting virtually on May 23, 2024, to vote on director elections, auditor ratification, and executive compensation.

Summary

  • Nevro Corp. is holding its 2024 Annual Meeting of Stockholders virtually on May 23, 2024.
  • Stockholders will vote on the election of ten directors.
  • They will also vote to ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
  • Additionally, a non-binding, advisory vote will be held on the compensation of the named executive officers.

Sentiment

Score: 5

Explanation: The document is a neutral announcement of a routine corporate event.

Industry Context

This is a standard annual meeting announcement, typical for publicly traded companies to fulfill their corporate governance obligations.

Stakeholder Impact

  • Shareholders have the opportunity to vote on key company matters.
  • The outcome of the votes can influence the direction and oversight of the company.

Next Steps

  • Stockholders are encouraged to review the proxy materials and vote on the proposals.
  • Attend the virtual Annual Meeting on May 23, 2024.

Key Dates

DateDescription
May 9, 2024Deadline to request a paper or email copy of proxy materials.
May 22, 2024Voting deadline at 11:59 PM ET.
May 23, 2024Annual Meeting of Stockholders at 10:30 AM PDT.
December 31, 2024Fiscal year end for which PricewaterhouseCoopers LLP is proposed as auditor.

Keywords

Annual Meeting, Stockholders, Proxy Statement, Nevro Corp, Voting, Directors, Auditor, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.